The World Health Organization brings together international experts in specific fields through its biological standardization programme to develop and revise specific recommendations for the production and quality control of vaccines of major international public health importance.
Authoritative, harmonized guidelines and recommendations, for use by manufacturers and regulatory authorities, are published in the reports of ECBS meetings in the WHO Technical Report Series.
General topics and regulatory guidance
- WHO Informal Consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products including biosimilars, Seoul, Republic of Korea, 27-28 April 2017
- Working Group meeting on revision of WHO TRS 941, Annex 5: WHO biosafety risk assessment and Guidelines for the production and quality control of human influenza pandemic vaccines, Geneva, Switzerland, 9-10 May 2017
- Working group meeting on Hepatitis E Vaccine, Geneva, Switzerland, 11-12 May 2017
Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971